Angiotensin receptor blockade and portal hypertension: Paradise gained and paradise lost

Gastroenterology

Volumn 121, Issue 2, 2001, Pages 487-490

  Sanyal, A J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ION; CAPTOPRIL; SARALASIN;

ARTERY CONSTRICTION; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; EDITORIAL; GENETIC POLYMORPHISM; HEPATIC VEIN; HUMAN; HYPOTENSION; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VENOCONSTRICTION; VENOUS PRESSURE;

EID: 0034898891     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.26770     Document Type: Article

References (22)

1. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
2. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
3. Effect of angiotensin-II blockade on systemic and hepatic hemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites
4. Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis
5. Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis
6. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis
7. Effects of angiotensin converting enzyme inhibitors and sclerotherapy on portal hemodynamics in patients with portal hypertension
8. Angiotensin II induces contraction and proliferation of human hepatic stellate cells
9. Endothelial dysfunction: From physiology to therapy
10. Genetic control of blood pressure and the angiotensinogen locus
11. Angiotensin convertase enzyme in the human heart. Effect of deletion/insertion polymorphism
12. ACE (I/D) genotype as predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalapril) in humans
13. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang(1-9) formed by heart carboxypeptidase A-like activity
14. Angiotensin receptors
15. Formulating clinical strategies for angiotensin antagonism: A review of preclinical and clinical studies
16. The versatility and universality of calcium signaling
17. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis
18. The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis
19. Electromechanical and pharmacomechanical coupling
20. Loss of angiotensin II receptors in portal hypertensive rabbits
21. Effect of endogenous angiotensin II on renal nerve activity and its arterial baroreceptor regulation
22. Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla